These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease. Bousamra M; Schumer E; Li M; Knipp RJ; Nantz MH; van Berkel V; Fu XA J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1074-80; discussion 1080-1. PubMed ID: 25129599 [TBL] [Abstract][Full Text] [Related]
46. Volatile signature for the early diagnosis of lung cancer. Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451 [TBL] [Abstract][Full Text] [Related]
47. Breath testing as a method for detecting lung cancer. Taivans I; Bukovskis M; Strazda G; Jurka N Expert Rev Anticancer Ther; 2014 Feb; 14(2):121-3. PubMed ID: 24467216 [TBL] [Abstract][Full Text] [Related]
48. Pentane and other volatile organic compounds, including carboxylic acids, in the exhaled breath of patients with Crohn's disease and ulcerative colitis. Dryahina K; Smith D; Bortlík M; Machková N; Lukáš M; Španěl P J Breath Res; 2017 Nov; 12(1):016002. PubMed ID: 28781264 [TBL] [Abstract][Full Text] [Related]
49. Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry. Ligor M; Ligor T; Bajtarevic A; Ager C; Pienz M; Klieber M; Denz H; Fiegl M; Hilbe W; Weiss W; Lukas P; Jamnig H; Hackl M; Buszewski B; Miekisch W; Schubert J; Amann A Clin Chem Lab Med; 2009; 47(5):550-60. PubMed ID: 19397483 [TBL] [Abstract][Full Text] [Related]
50. Exhaled breath analysis in interstitial lung disease. van der Sar IG; Wijsenbeek MS; Moor CC Curr Opin Pulm Med; 2023 Sep; 29(5):443-450. PubMed ID: 37405699 [TBL] [Abstract][Full Text] [Related]
51. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting. Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557 [TBL] [Abstract][Full Text] [Related]
52. Detection of volatile organic compounds in exhaled breath to screen lung cancer: a systematic review. Hua Q; Zhu Y; Liu H Future Oncol; 2018 Jul; 14(16):1647-1662. PubMed ID: 29939068 [TBL] [Abstract][Full Text] [Related]
53. Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm. Sakumura Y; Koyama Y; Tokutake H; Hida T; Sato K; Itoh T; Akamatsu T; Shin W Sensors (Basel); 2017 Feb; 17(2):. PubMed ID: 28165388 [TBL] [Abstract][Full Text] [Related]
54. Comparison of Targeted and Untargeted Approaches in Breath Analysis for the Discrimination of Lung Cancer from Benign Pulmonary Diseases and Healthy Persons. Koureas M; Kalompatsios D; Amoutzias GD; Hadjichristodoulou C; Gourgoulianis K; Tsakalof A Molecules; 2021 Apr; 26(9):. PubMed ID: 33946997 [TBL] [Abstract][Full Text] [Related]
55. Exhaled volatile organic compounds analysis in clinical pediatrics: a systematic review. Sola Martínez RA; Pastor Hernández JM; Yanes Torrado Ó; Cánovas Díaz M; de Diego Puente T; Vinaixa Crevillent M Pediatr Res; 2021 May; 89(6):1352-1363. PubMed ID: 32919397 [TBL] [Abstract][Full Text] [Related]
56. Do linear logistic model analyses of volatile biomarkers in exhaled breath of cystic fibrosis patients reliably indicate Pseudomonas aeruginosa infection? Španěl P; Sovová K; Dryahina K; Doušová T; Dřevínek P; Smith D J Breath Res; 2016 Aug; 10(3):036013. PubMed ID: 27532768 [TBL] [Abstract][Full Text] [Related]
57. Sensors for detecting pulmonary diseases from exhaled breath. Hashoul D; Haick H Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31243097 [TBL] [Abstract][Full Text] [Related]
58. Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review. van de Kant KD; van der Sande LJ; Jöbsis Q; van Schayck OC; Dompeling E Respir Res; 2012 Dec; 13(1):117. PubMed ID: 23259710 [TBL] [Abstract][Full Text] [Related]
59. Exhaled volatile organic compounds as lung cancer biomarkers during one-lung ventilation. Wang C; Dong R; Wang X; Lian A; Chi C; Ke C; Guo L; Liu S; Zhao W; Xu G; Li E Sci Rep; 2014 Dec; 4():7312. PubMed ID: 25482491 [TBL] [Abstract][Full Text] [Related]